Latest Period
Q1 2026
Security Snapshot
COLLEGIUM PHARMACEUTICAL, INC - Common Stock (COLL) Institutional Ownership
CUSIP: 19459J104
13F Institutional Holders and Ownership History from Q2 2015 to Q1 2026
Institutions Reporting
265
Shares (Excl. Options)
37,713,359
Price
$33.07
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- COLL on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 37,713,359
- Total 13F value
- $1,247,670,906
- Portfolio coverage rank
- 0%
- Share change
- +800,846
- Value change
- +$10,095,548
- Number of holders
- 265
- Shares outstanding
- 31,476,741
- SEC-reported price per share
- $39.33
- Insider filing price
- $39.33
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- COLL - COLLEGIUM PHARMACEUTICAL, INC - Common Stock is tracked under CUSIP 19459J104.
- 265 institutions reported positions in Q1 2026.
- 9 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 278 to 265 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $1,718,563,197 to $1,247,670,906.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 265 institutions filings for Q1 2026.
Security key
19459J104
Latest holder period
Q1 2026
13F holders
265
13D/G owners
9
CIK / CUSIP context first
Open Q1 2026 holders
COLL full holder history
COLLEGIUM PHARMACEUTICAL, INC SEC filings
COLLEGIUM PHARMACEUTICAL, INC company facts
COLLEGIUM PHARMACEUTICAL, INC insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 19459J104:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
9
Security
COLL
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 16% | $133,841,807 | 4,997,827 | BlackRock, Inc. | 31 Mar 2025 | |||
| JANUS HENDERSON GROUP PLC | 5.8% | $60,374,279 | 1,825,651 | JANUS HENDERSON GROUP PLC | 31 Mar 2026 | |||
| Invesco Ltd. | 5% | +2% | $52,644,431 | +$232,747 | 1,591,909 | +0.44% | Invesco Ltd. | 31 Mar 2026 |
| INTEGRATED CORE STRATEGIES (US) LLC | 4.7% | $50,249,865 | 1,519,500 | Millennium Management LLC | 07 May 2026 | |||
| Rubric Capital Management LP | 4.7% | -51% | $68,132,731 | -$68,457,269 | 1,496,436 | -50% | Rubric Capital Management LP | 31 Dec 2025 |
| RENAISSANCE TECHNOLOGIES LLC | 4.5% | -11% | $48,594,678 | -$4,290,502 | 1,469,449 | -8.1% | Renaissance Technologies LLC | 08 Jan 2026 |
| PRINCIPAL GLOBAL INVESTORS | 4.6% | $44,508,457 | 1,466,506 | PRINCIPAL GLOBAL INVESTORS | 30 Jun 2025 | |||
| EVENTIDE ASSET MANAGEMENT, LLC | 4.5% | -23% | $47,101,006 | -$14,946,218 | 1,424,282 | -24% | Eventide Asset Management, LLC | 31 Mar 2026 |
| Pacer Advisors, Inc. | 1.1% | -87% | $11,222,855 | -$46,153,054 | 419,076 | -80% | Pacer Advisors, Inc. | 31 Mar 2025 |
As of 31 Mar 2026, 265 institutional investors reported holding 37,713,359 shares of COLLEGIUM PHARMACEUTICAL, INC - Common Stock (COLL). This represents 120% of the company’s total 31,476,741 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
90%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 16% | 5,134,027 | +0.67% | 0% | $169,782,275 |
| JANUS HENDERSON GROUP PLC | 5.8% | 1,825,651 | +26% | 0.03% | $60,357,711 |
| Invesco Ltd. | 5.1% | 1,591,909 | +35% | 0.01% | $52,644,432 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4.8% | 1,499,584 | -0.03% | 0.17% | $49,591,238 |
| RENAISSANCE TECHNOLOGIES LLC | 4.7% | 1,469,449 | -9.1% | 0.08% | $48,594,678 |
| STATE STREET CORP | 4.5% | 1,424,544 | +8.7% | 0% | $47,109,670 |
| EVENTIDE ASSET MANAGEMENT, LLC | 4.5% | 1,424,282 | -24% | 0.78% | $47,083,833 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 4.3% | 1,365,932 | +4.1% | 0.02% | $45,171,371 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.2% | 1,333,992 | 0% | 0% | $44,115,115 |
| PRINCIPAL FINANCIAL GROUP INC | 4.1% | 1,295,028 | -1.4% | 0.02% | $42,826,576 |
| Rubric Capital Management LP | 4.1% | 1,279,611 | -14% | 0.52% | $42,316,736 |
| DIMENSIONAL FUND ADVISORS LP | 2.6% | 833,192 | +0.33% | 0.01% | $27,550,723 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.6% | 819,440 | -1.2% | 0% | $27,104,738 |
| MARSHALL WACE, LLP | 2.4% | 748,812 | +52% | 0.03% | $24,763,215 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2.2% | 703,528 | +29% | 0.01% | $23,265,671 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.2% | 680,381 | 0% | 0% | $22,500,200 |
| VICTORY CAPITAL MANAGEMENT INC | 2% | 625,304 | +37% | 0.01% | $20,678,803 |
| Qube Research & Technologies Ltd | 2% | 621,935 | +132% | 0.03% | $20,567,390 |
| TWO SIGMA INVESTMENTS, LP | 1.9% | 590,116 | +61% | 0.02% | $19,515,136 |
| GOLDMAN SACHS GROUP INC | 1.8% | 575,141 | -11% | 0% | $19,019,913 |
| D. E. Shaw & Co., Inc. | 1.7% | 530,698 | -19% | 0.01% | $17,550,183 |
| MORGAN STANLEY | 1.6% | 515,179 | -25% | 0% | $17,036,980 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.6% | 495,027 | +11% | 0% | $16,370,543 |
| AMERICAN CENTURY COMPANIES INC | 1.5% | 460,744 | +122% | 0.01% | $15,236,804 |
| EMERALD ADVISERS, LLC | 1.3% | 402,752 | -36% | 0.42% | $13,319,009 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
44
Latest
Q1 2026
Rows shown
1-25 of 44
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 37,713,359 | $1,247,670,906 | +$10,095,548 | $33.07 | 265 |
| 2025 Q4 | 37,127,091 | $1,718,563,197 | +$3,842,171 | $46.30 | 278 |
| 2025 Q3 | 36,987,734 | $1,294,013,273 | +$43,990,267 | $34.99 | 241 |
| 2025 Q2 | 35,739,346 | $1,056,745,851 | -$27,671,390 | $29.57 | 221 |
| 2025 Q1 | 36,773,847 | $1,097,284,609 | -$11,471,996 | $29.85 | 241 |
| 2024 Q4 | 37,138,457 | $1,064,290,472 | -$54,467,577 | $28.65 | 238 |
| 2024 Q3 | 38,489,790 | $1,486,827,407 | -$25,778,054 | $38.64 | 248 |
| 2024 Q2 | 39,660,571 | $1,277,281,895 | -$10,053,520 | $32.20 | 229 |
| 2024 Q1 | 39,565,870 | $1,535,798,999 | +$15,800,408 | $38.82 | 226 |
| 2023 Q4 | 39,202,475 | $1,206,720,767 | +$15,870,252 | $30.78 | 190 |
| 2023 Q3 | 38,712,156 | $865,246,259 | -$10,117,275 | $22.35 | 174 |
| 2023 Q2 | 39,246,501 | $843,481,973 | +$2,463,793 | $21.49 | 177 |
| 2023 Q1 | 39,049,844 | $936,805,999 | +$74,091,480 | $23.99 | 196 |
| 2022 Q4 | 36,094,328 | $837,390,551 | +$6,535,089 | $23.20 | 174 |
| 2022 Q3 | 35,876,068 | $574,780,379 | -$19,538,698 | $16.02 | 158 |
| 2022 Q2 | 36,430,591 | $645,532,750 | +$14,193,849 | $17.72 | 152 |
| 2022 Q1 | 36,080,262 | $733,927,682 | +$6,776,837 | $20.36 | 161 |
| 2021 Q4 | 35,805,022 | $668,826,744 | -$13,881,763 | $18.68 | 152 |
| 2021 Q3 | 36,444,427 | $719,484,752 | -$39,361,775 | $19.74 | 150 |
| 2021 Q2 | 37,987,862 | $898,085,585 | -$27,328 | $23.64 | 155 |
| 2021 Q1 | 38,008,378 | $900,688,845 | +$32,135,922 | $23.70 | 161 |
| 2020 Q4 | 37,131,836 | $744,007,768 | -$8,934,464 | $20.03 | 135 |
| 2020 Q3 | 39,011,062 | $812,260,717 | +$4,160,811 | $20.82 | 140 |
| 2020 Q2 | 37,020,602 | $647,728,854 | +$3,968,987 | $17.50 | 149 |
| 2020 Q1 | 36,901,564 | $602,550,993 | +$85,027,216 | $16.33 | 157 |